ATLANTA, Aug. 19, 2020 /PRNewswire/ -- SoftWave® Tissue Regeneration Technologies, a disruptive bio-medical device company, announces the beginning of a trial for "Extracorporeal Shock Wave Therapy in Acute Traumatic Complete and Incomplete Cross - Sectional Lesions." The trial will be...